LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .6. PHARMACOKINETICS OF THEENANTIOMERS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA, URINE AND CEREBROSPINAL-FLUID
Gp. Kaijser et al., LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .6. PHARMACOKINETICS OF THEENANTIOMERS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA, URINE AND CEREBROSPINAL-FLUID, Journal of drug development and clinical practice, 7(4), 1996, pp. 319-326
A chiral gas chromatographic method was used to determine the concentr
ation and enantiomeric ratios of ifosfamide, 2- and 3-dechloroethylifo
sfamide in plasma, urine and cerebrospinal fluid samples from 10 patie
nts treated with ifosfamide. It appeared that some metabolic preferenc
e exists for S-ifosfamide. However, this preference does not always le
ad to a higher excretion of the metabolite isomers, S-2- and R-3-dechl
oroethylifosfamide originating from S-ifosfamide. The differences in s
tereospecific metabolism could not be correlated with age, sex, durati
on of the infusion of ifosfamide dose.